BillTracking.org
Back to the feed

Home › US bills › S. 3788

United States

S. 3788

CLEAR LABELS Act

Health, Education, Labor, and Pensions Committee · Sen. Rick Scott (R-FL)

The bill would require drug manufacturers to label their products with information about who originally made the active ingredients and the finished drug, as well as any packers or distributors involved. This labeling information could appear on the product itself or be made available electronically, and the FDA would have authority to penalize companies that fail to comply, though it would consider factors like whether companies were given a chance to fix violations before imposing fines.[AI-Generated]

Reported by committee 27 July 2026

Record as of 27 July 2026 — the most recent action in the official record. Status can lag; each step below carries its own date.

  1. 27 July 2026 Reported by committee

    What's next: Floor scheduling (leadership decides if and when it gets a vote)

  2. 27 July 2026 Placed on calendar (Senate)
    2 more actions
    1. 22 July 2026 Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.
    2. 19 March 2026 Committee on Health, Education, Labor, and Pensions. Hearings held.
  3. 5 February 2026 Referred to 2 committees
  4. 5 February 2026 Introduced in Senate
This path starts where the bill does — its first action in the official record. Routine procedural steps sit in the “more actions” rows above rather than on the main line.

Read the live feed — on the site or in the app Look up S. 3788 on Congress.gov All US bills